Lung Resections for Elderly Patients with Lung Metastases: A Comparative Study of the Postoperative Complications and Overall Survival.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
26 06 2022
Historique:
received: 19 05 2022
revised: 16 06 2022
accepted: 24 06 2022
entrez: 25 7 2022
pubmed: 26 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

Background: Pulmonary metastasectomy (PM) is an established treatment option for selected patients with stage IV solid tumors. The aim of this study was to investigate the feasibility of and survival rate in PM for elderly patients. Methods: We retrospectively analyzed all of the patients who underwent PM with curative intention at our institution. The patients were categorized into two groups: the elderly group (≥70 years old) and the non-elderly group (<70 years old). Results: The elderly group consisted of 222 patients versus 538 patients in the non-elderly group. The median number of resected metastases was 2 ± 3 in the elderly group and 4 ± 5 in the non-elderly group (p < 0.01). No difference in the rate of postoperative complications was observed between the two groups (p = 0.3). The median length of hospital stay in each group was comparable (10 ± 5 vs. 10 ± 4.3 days, p = 0.3). The 5-year survival rate was 67% in the elderly group and 78% in the non-elderly group (p = 0.117). In the univariate analysis, COPD was associated with poor survival in the elderly group (p = 0.002). Conclusion: The resection of pulmonary metastases in elderly patients is safe, is not associated with increased risks of postoperative complication, and the survival benefit is not reduced in selected patients.

Identifiants

pubmed: 35877217
pii: curroncol29070357
doi: 10.3390/curroncol29070357
pmc: PMC9323760
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4511-4521

Références

Int J Colorectal Dis. 2018 Oct;33(10):1401-1409
pubmed: 30056558
Curr Opin Oncol. 2007 Mar;19(2):84-91
pubmed: 17272978
Eur J Anaesthesiol. 2015 Feb;32(2):88-105
pubmed: 25058504
Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1893-907
pubmed: 20647400
Mayo Clin Proc. 2018 Oct;93(10):1488-1502
pubmed: 30286833
CA Cancer J Clin. 2013 Jan;63(1):11-30
pubmed: 23335087
Ann Thorac Surg. 2009 Jun;87(6):1684-8
pubmed: 19463577
Semin Oncol. 2004 Apr;31(2):128-36
pubmed: 15112144
Eur J Cardiothorac Surg. 2014 Apr;45(4):671-6
pubmed: 24092503
Updates Surg. 2016 Dec;68(4):357-367
pubmed: 27677469
Int J Chron Obstruct Pulmon Dis. 2007;2(4):493-515
pubmed: 18268924
Eur J Cardiothorac Surg. 2007 Feb;31(2):167-72
pubmed: 17150367
Ann Thorac Surg. 2001 Oct;72(4):1149-54
pubmed: 11603428
Arch Bronconeumol. 2009 May;45(5):235-9
pubmed: 19395141
Ann Thorac Surg. 2007 Jul;84(1):203-10
pubmed: 17588413
Ann Thorac Surg. 2017 Oct;104(4):1194-1199
pubmed: 28760464
Ann Surg. 2019 Dec;270(6):1170-1177
pubmed: 29781848
Ann Thorac Surg. 2010 Sep;90(3):936-42; discussion 942
pubmed: 20732521
Transl Oncol. 2021 May;14(5):101021
pubmed: 33621740
Dtsch Arztebl Int. 2012 Oct;109(40):645-51
pubmed: 23094000
Ann Surg Oncol. 1999 Sep;6(6):572-8
pubmed: 10493626

Auteurs

Mohamed Hassan (M)

Department of Thoracic Surgery, Medical Center-University of Freiburg, 79106 Freiburg im Breisgau, Germany.
Faculty of Medicine, University of Freiburg, 79106 Freiburg im Breisgau, Germany.

Benjamin Ehle (B)

Department of Thoracic Surgery, Medical Center-University of Freiburg, 79106 Freiburg im Breisgau, Germany.
Faculty of Medicine, University of Freiburg, 79106 Freiburg im Breisgau, Germany.

Bernward Passlick (B)

Department of Thoracic Surgery, Medical Center-University of Freiburg, 79106 Freiburg im Breisgau, Germany.
Faculty of Medicine, University of Freiburg, 79106 Freiburg im Breisgau, Germany.

Konstantinos Grapatsas (K)

Department of Thoracic Surgery, Medical Center-University of Freiburg, 79106 Freiburg im Breisgau, Germany.
Faculty of Medicine, University of Freiburg, 79106 Freiburg im Breisgau, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH